Session

Nephron sparing surgery: Renal function preservation and outcome

Poster Session 77

  • Location:
    Room Milan (Hall B2, level 0)
  • Chairs:
     A. Bex, Amsterdam (NL)
     K. Touijer, New York (US)
  • Aims and objectives of this session

    To discuss outcomes of nephron-sparing surgery with regard to kidney function and Long-term cardiovascular mortality.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
974
Impact of preoperative proteinuria on postoperative renal functional outcome after open partial nephrectomy: A propensity score matching study

By: Tachibana H., Takagi T., Iizuka J., Kondo T., Tanabe K.

Institutes: Tokyo Women’s Medical University, Dept. of Urology, Tokyo, Japan

975
Preoperative plasma fibrinogen level as a significant prognostic factor in patients with localized renal cell carcinoma after surgical treatment

By: Lee H.1, Oh J.J.1, Byun S-S.1, Lee S.E.1, Kwak C.2, Kim H.H.2, Hong S.K.1

Institutes: 1Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 2Seoul National University Hospital, Dept. of Urology, Seongnam, South Korea

976
Predictors of overall and new-onset renal function impairment after partial nephrectomy: Results from two-years follow up of a prospective multicentre study (RECORd 1 project)

By: Minervini A.1, Mari A.1, Campi R.1, Novara G.2, Antonelli A.3, Bertolo R.4, Bianchi G.5, Fiori C.4, Giancane S.1, Longo N.6, Mirone V.6, Morgia G.7, Porpiglia F.4, Schiavina R.8, Serni S.1, Simeone C.3, Sodano M.3, Rocco B.9, Terrone C.10, Carini M.1

Institutes: 1University of Florence, Dept. of Urology, Florence, Italy, 2University of Padua, Dept. of Urology, Padua, Italy, 3Spedali Civili, Dept. of NephroUrology, Brescia, Italy, 4University of Turin, S.Luigi Gonzaga Hospital, Dept. of Urology, Turin, Italy, 5University of Modena, Dept. of Urology, Modena, Italy, 6University of Naples, Federico II, Dept. of Urology, Naples, Italy, 7Luna Foundation, -, Italy, 8University of Bologna, S. Orsola-Malpighi Hospital, Dept. of Urology, Bologna, Italy, 9University of Milan, IRCCS Ca’ Granda Hospital, Dept. of Urology, Milan, Italy, 10A.O. Maggiore Della Carità Hospital, Dept. of Urology, Novara, Italy

977
Nephron sparing surgery decreases other-causes mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma

By: Larcher A.1, Capitanio U.1, Terrone C.2, Dehò F.1, Volpe A.2, Antonelli A.3, Minervini A.4, Fiori C.5, Furlan M.3, Serni S.4, Carini M.4, Novara G.5, Porpiglia F.5, Simeone C.3, Fossati N.1, Briganti A.1, Montorsi F.1, Bertini R.1

Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Oncology and Urology, Milan, Italy, 2University of Piemonte Orientale, Dept. of Urology, Novara, Italy, 3Universita’ Degli Studi E Spedali Civili Di Brescia, Dept. of Urology, Brescia, Italy, 4Clinica Urologica I, Azienda Ospedaliera Universitaria Careggi, Università Degli Studi Di Firenze, Dept. of Urology, Florence, Italy, 5Azienda Ospedaliera Universitaria San Luigi Gonzaga, Dept. of Urology, Turin, Italy

978
Diabetes mellitus as an independent predictor of survival of patients surgically treated for renal cell carcinoma: A propensity score matching study

By: Lee H.1, Song B.1, Kwak C.2, Kim H.H.2, Byun S-S.1, Lee S.E.1, Kook H.R.1, Hong S.K.1

Institutes: 1Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 2Seoul National University Hospital, Dept. of Urology, Seoul, South Korea

979
Assessment of long term functional outcomes in more than 1000 patients treated with minimally ischemic partial nephrectomy

By: Simone G.1, Misuraca L.1, Papalia R.2, Ferriero M.1, Mastroianni R.2, Minisola F.1, Tuderti G.1, Pompeo V.1, Costantini M.1, Guaglianone S.1, Muto G.2, Gallucci M.1

Institutes: 1“Regina Elena” National Cancer Institute, Dept. of Urology, Rome, Italy, 2Campus Biomedico University, Dept. of Urology, Rome, Italy

980
Zero ischemia resection of renal masses has no benefit on mid-term renal function: Results from a nephrometry matched pair analysis

By: Kriegmair M.1, Mandel P.2, Huck N.1, Fenner L.1, Wagener N.1, Michel M-S.1, Pfalzgraf D.1

Institutes: 1University Medical Center Mannheim, Dept. of Urology, Mannheim, Germany, 2University Medical Centre Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany

981
Do we really need to perform partial nephrectomy with zero ischemia?

By: Volkova M., Matveev V., Figurin K., Chernyaev V., Klimov A.

Institutes: N.N. Blokhin Russian Cancer Research Center, Dept. of Urology, Moscow, Russia

982
Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease

By: Kawamura N., Yokoyama M., Fujii Y., Inoue M., Ito M., Yoshida S., Ishioka J., Numao N., Matsuoka Y., Saito K., Kihara K.

Institutes: Tokyo Medical and Dental University Graduate School, Dept. Of Urology, Tokyo, Japan

983
Intraoperative, postoperative and functional outcomes of clampless laparoscopic partial nephrectomy (LPN) for renal tumours with high surgical complexity

By: Chiancone F.1, Fedelini P.2, Meccariello C.2, Fedelini M.2, Carrino M.2, Giannella R.2, Venturino L.1, Verze P.1, Imbimbo C.1, Mirone V.1

Institutes: 1University of Naples Federico II, Dept. of Urology, Naples, Italy, 2A.O.R.N. A. Cardarelli, Dept. of Urology, Naples, Italy

984
Partial nephrectomy shows significant benefit over radical nephrectomy in older patient and patients with arterial hypertension

By: Pop D.1, Bütow Z.1, Elsäßer J.1, Saar M.1, Heinzelbecker J.1, Ohlmann C.1, Siemer S.1, Gräber S.2, Stöckle M.1, Janssen M.1

Institutes: 1UKS Universitätsklinikum des Saarlandes, Dept. of Urology and Child Urology, Homburg/Saar, Germany, 2UKS Universitätsklinikum des Saarlandes, Institute Medical Biometric, Epidemiology and Medical Informattion, Homburg/Saar, Germany

985
Value of partial nephrectomy across the tumour size spectrum: A risk-benefit analysis of renal function preservation versus increased morbidity

By: Vilaseca Cabo A.1, Guglielmetti G.1, Vertosick E.2, Sjoberg D.2, Grasso A.1, Benfante N.2, Coleman J.1, Russo P.1, Vickers A.2, Touijer K.1

Institutes: 1Memorial Sloan-Kettering Cancer Center, Dept. of Urology, New York, United States of America, 2Memorial Sloan-Kettering Cancer Center, Epidemiology and Biostatistics, New York, United States of America

Summary and context
 K. Touijer, New York (US)